A determining factor in efficacy of oncolytic virus therapy with HSV-1 for hematologic malignancies

Ryo Ishino

Presentation information

Oral Session

Oral Session 1-11B Basic and clinical studies for immunotherapy

Fri. Oct 12, 2018 10:10 AM - 11:10 AM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Norimitsu Kadowaki (Faculty of Medicine, Kagawa University, Japan)

[OS1-11B-4] A determining factor in efficacy of oncolytic virus therapy with HSV-1 for hematologic malignancies

Ryo Ishino^1,2, Yumi Kawase¹, Toshio Kitawaki¹, Naoshi Sugimoto^2,3, Yasushi Ino⁴, Tomoki Todo⁴, Akifumi Takaori-Kondo¹, Norimitsu Kadowaki² (1.Department of Hematology and Oncology, Kyoto Univ., Kyoto, Japan., 2.Division of Hematology, Rheumatology and Respiratory, Kagawa University, Kagawa, Japan., 3.CiRA., Kyoto University, Kyoto, Japan., 4.Division of Innovative Cancer Therapy, IMSUT, Tokyo, Japan.)

Abstract password authentication.
Password is written on a program and abstract book.